CUROHOLDINGS Co., Ltd. (KOSDAQ:051780)

Market Cap	18.19B
Revenue (ttm)	62.36B
Net Income (ttm)	-15.90B
Shares Out	23.17M
EPS (ttm)	-1,124.67
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,993
Average Volume	44,346
Open	803.00
Previous Close	803.00
Day's Range	781.00 - 803.00
52-Week Range	509.00 - 3,350.00
Beta	0.31
RSI	49.64
Earnings Date	Aug 12, 2025

About Revance Therapeutics

CUROHOLDINGS Co., Ltd. engages in the entertainment and coffee businesses in South Korea. The company engages in movies business, that includes film and agency business; and dramas, as well as casting, nurturing, and managing actors, models, and others. Its coffee business distributes coffee and coffee machines under the illy brand to hotels and lounges of department stores; and sells capsule machines, such as Francis X7.1 through department stores and online shopping malls, as well as distributes coffee beans to hotels, businesses, and cafes. ...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1985
• Employees: 47
• Stock Exchange: KOSDAQ
• Ticker Symbol: 051780

Financial Performance

In 2024, CUROHOLDINGS's revenue was 61.10 billion, a decrease of -23.41% compared to the previous year's 79.77 billion. Losses were -15.93 billion, 109.2% more than in 2023.